GB62237
BTA-9881
Also known as (2S)-2-(4-chlorophenyl)-3-(pyridine-3-carbonyl)-3,6,11-triazatricyclo[6.4.0.02,6]dodeca-1(8),9,11-trien-7-one
BTA-9881, also known as AZD-9639 and MEDI-564, is a viral fusion protein inhibitor potentially for the treatment of respiratory syncytial virus infection
ChemicalCAS1646857-24-0MW390.827FormulaC21H15ClN4O2
- CAS number
- 1646857-24-0
- Molecular weight
- 390.827
- Formula
- C21H15ClN4O2
- Solubility
- Soluble in DMSO
- InChIKey
- QZSZPSDRJPPZDZ-OAQYLSRUSA-N
- Catalogue number
- GB62237
- Brand
- GLPBIO
Computed properties PubChem CID 70807574 · XLogP 2 · TPSA 66.4 Ų · H-bond donors 0
- XLogP
- 2
- TPSA
- 66.4 Ų
- H-bond donors
- 0
- H-bond acceptors
- 4
- Rotatable bonds
- 2
- Heavy atoms
- 28
SMILES C1CN([C@@]2(N1C(=O)C3=C2C=NC=C3)C4=CC=C(C=C4)Cl)C(=O)C5=CN=CC=C5
Computed descriptors from PubChem (CID 70807574), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il